CIK 0000908259 · Non-accelerated filer<br>Smaller reporting company
Oncotelic Therapeutics, Inc.
Sign in to watch- Ticker
- OTLC
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133679168
- Phone
- 650-635-7000
- Business address
- 29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
- Former names
- MATEON THERAPEUTICS INC, OXIGENE INC
- Open-market buys, last 90 days
- $23,537
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$23,537. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 71 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-09-20 | McMahon Gerald PhD Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2011-01-02 | Wood Alastair JJ Director | Grant or award | +25,000 | $0.23 | $6K | 115,000 |
| 2011-01-02 | Schwieterman William D Director | Grant or award | +25,000 | $0.23 | $6K | 179,208 |
| 2011-01-02 | SHIEBLER WILLIAM N Director | Grant or award | +25,000 | $0.23 | $6K | 236,002 |
| 2011-01-02 | KESSEL MARK Director | Grant or award | +25,000 | $0.23 | $6K | 115,000 |
| 2011-01-02 | HOWSON TAMAR D Director | Grant or award | +25,000 | $0.23 | $6K | 75,000 |
| 2011-01-02 | FICKLING ROY H Director | Grant or award | +25,000 | $0.23 | $6K | 202,846 |
| 2010-09-15 | LANGECKER PETER Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2010-09-15 | CHAPLIN DAVID Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2010-09-15 | MURPHY JAMES B Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2010-07-01 | HOWSON TAMAR D Director | Grant or award | +25,000 | $0.38 | $10K | 50,000 |
| 2010-07-01 | Wood Alastair JJ Director | Grant or award | +25,000 | $0.38 | $10K | 90,000 |
| 2010-07-01 | Schwieterman William D Director | Grant or award | +25,000 | $0.38 | $10K | 154,208 |
| 2010-07-01 | SHIEBLER WILLIAM N Director | Grant or award | +25,000 | $0.38 | $10K | 292,002 |
| 2010-07-01 | KESSEL MARK Director | Grant or award | +25,000 | $0.38 | $10K | 27,297,118 |
| 2010-07-01 | HOWSON TAMAR D Director | Sale | +25,000 | $0.39 | $10K | 50,000 |
| 2010-07-01 | FICKLING ROY H Director | Grant or award | +25,000 | $0.38 | $10K | 177,846 |
| 2010-04-27 | MURPHY JAMES B Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2010-04-27 | CHAPLIN DAVID Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2010-04-27 | LANGECKER PETER Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 |
Page 9 of 17 · 340 trades